Molecular Partners AG (MOLN)

NASDAQ: MOLN · IEX Real-Time Price · USD

3.745

+0.025 (0.67%)

At close: May 17, 2024, 3:58 PM

3.620

-0.125 (-3.34%)

After-hours: May 17, 2024, 4:00 PM EDT

Molecular Partners AG Income Statement

Financials in millions CHF. Fiscal year is January - December.

Millions CHF. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019
Revenue	7.04	189.6	9.75	9.34	20.38
Revenue Growth (YoY)	-96.29%	1843.82%	4.39%	-54.16%	-
Gross Profit	7.04	189.6	9.75	9.34	20.38
Selling, General & Admin	19.36	22.24	17.45	11.6	13.55
Research & Development	48.78	50.75	55.72	56.08	43.5
Operating Expenses	68.15	72.99	73.17	67.67	57.04
Operating Income	-61.11	116.61	-63.42	-58.33	-36.66
Interest Expense / Income	5.16	0.62	0.56	4.82	1.21
Other Expense / Income	-4.28	-1.86	-0.19	-0.37	-1.6
Pretax Income	-61.98	117.85	-63.78	-62.78	-36.27
Income Tax	0	0	0	-0.01	0.02
Net Income	-61.98	117.85	-63.79	-62.76	-36.29
Shares Outstanding (Basic)	33	33	32	32	-
Shares Change	0.99%	1.11%	-	-	-
EPS (Basic)	-1.89	3.63	-2.06	-2.51	-1.69
EPS (Diluted)	-1.89	3.54	-2.06	-2.51	-1.69
Free Cash Flow	-59.58	117.39	-91.89	-30.43	-2.22
Free Cash Flow Per Share	-1.81	3.61	-2.86	-0.95	-
Gross Margin	100.00%	100.00%	100.00%	100.00%	100.00%
Operating Margin	-868.26%	61.50%	-650.17%	-624.21%	-179.86%
Profit Margin	-880.70%	62.16%	-653.94%	-671.70%	-178.03%
Free Cash Flow Margin	-846.55%	61.91%	-942.03%	-325.71%	-10.89%
EBITDA	-54.41	120.86	-60.66	-55.07	-32.59
EBITDA Margin	-773.07%	63.74%	-621.92%	-589.38%	-159.90%
Depreciation & Amortization	2.42	2.39	2.57	2.89	2.47
EBIT	-56.83	118.47	-63.23	-57.96	-35.06
EBIT Margin	-807.46%	62.49%	-648.22%	-620.28%	-172.01%

Source: Financials are provided by Nasdaq Data Link and sourced from audited reports submitted to the Securities and Exchange Commission (SEC).